Search a title or topic

Over 20 million podcasts, powered by 

Player FM logo

CMS Antitrust Podcasts

show episodes
 
Artwork

1
Competition+

CMS Antitrust, Competition & Trade Group

icon
Unsubscribe
icon
icon
Unsubscribe
icon
Monthly
 
Trending topics in competition law and beyond. In this podcast series, we explore trending topics in competition law, bringing you insights into how these shape markets and commerce. Competition+, also dives deeper, covering the critical areas of law that impact market conduct, including trade law, state aid and procurement laws as well as other forms of market regulation.
  continue reading
 
Artwork
 
Inside 340B Report is your exclusive, behind-the-scenes window into the latest news and developments in the 340B drug pricing program, straight from the journalists at 340B Report. Each episode, published twice a month, brings listeners inside 340B Report’s newsroom for a candid, insider’s perspective on the evolving drug pricing policy landscape from the journalists who cover it daily.
  continue reading
 
Loading …
show series
 
Episode 18: Impending Rebate Guidance, Possible 340B Move from HRSA to CMS & Oklahoma’s Veto Override In this episode, 340B Report Publisher and CEO Ted Slafsky, Associate Editors and Senior Writers Shannon Young and Will Newton and National Correspondent Bella Czajkowski break down the latest in 340B news, including the U.S. Department of Health a…
  continue reading
 
In this episode, 340B Report Publisher and CEO Ted Slafsky and Associate Editor and Senior Writers Shannon Young and Will Newton break down the latest in 340B news, including a major federal court ruling on drugmaker 340B rebate models, Health and Human Services (HHS) Secretary Robert F Kennedy Jr.’s first public comments on the 340B program and th…
  continue reading
 
In this episode, 340B Report Publisher and CEO Ted Slafsky, Associate Editor and Senior Writers Shannon Young and Will Newton and National Correspondent Bella Czajkowski break down the latest in 340B news, including developments in two major 340B lawsuits, new state contract pharmacy access laws with unique twists and developments on health funding…
  continue reading
 
In this episode, 340B Report Publisher & CEO Ted Slafsky joins Associate Editors and Senior Writers Shannon Young and Will Newton and National Correspondent Bella Czajkowski to break down the latest developments in the 340B space. The team discusses Senate HELP Committee Chair Bill Cassidy’s (R-La.) high-profile report on the 340B program, an execu…
  continue reading
 
Labour markets have been under intense scrutiny lately with both the European Commission and national competition authorities in the EU looking into various forms of anti-competitive agreements affecting labour markets. In this episode of Competition+ we dive into the complex world of no-poach agreements, which are essentially arrangements between …
  continue reading
 
In this episode, 340B Report Associate Editors and Senior Writers Shannon Young and Will Newton and National Correspondent Bella Czajkowski break down the latest in 340B news, including the latest states to enact contract pharmacy access laws, updates in key lawsuits and new U.S. Department of Health and Human Services (HHS) restructuring efforts. …
  continue reading
 
In this episode, the Inside 340B Report team dives into a flurry of activity at the state and federal levels. Publisher and CEO Ted Slafsky and Associate Editor/Senior Writers Shannon Young and Will Newton break down the unprecedented wave of state-level 340B contract pharmacy access and provider reporting bills, explore key federal movements, incl…
  continue reading
 
In this episode of Inside 340B Report, Ted Slafsky, Will Newton and Bella Czajkowski explore the latest developments in the 340B world at both the state and federal levels. They cover the progress of contract pharmacy access bills across the country—including a breaking news development—plus dark money efforts to oppose the legislation. They also b…
  continue reading
 
Dawn raids are an evergreen in the world of competition law. EU competition authorities use this powerful investigative tool to uncover cartels. A dawn raid is also a process in which the inspectors are more experienced and the staff under extreme pressure. It can lead to costly mistakes as the authorities protect their investigative powers by impo…
  continue reading
 
In this episode of Inside 340B Report, Ted Slafsky, Shannon Young, Will Newton and Bella Czajkowski discuss what may be a record-breaking year for state contract pharmacy access legislation with more than 20 states having already introduced such bills in 2025. On the federal front, the U.S. House's budget blueprint targeting $880 billion in health …
  continue reading
 
Episode 10: State-Level 340B Bills Gain Momentum, Dark Money Ads Intensify and D.C. Developments In this episode of Inside 340B Report, Ted, Shannon, Will and Bella break down the latest developments shaping the 340B landscape. The team discusses the latest state contract pharmacy bill developments and a dark-money group’s lobbying against them. Th…
  continue reading
 
In this episode of Inside 340B Report, Associate Editors Shannon Young and Will Newton and National Correspondent Bella Czajkowski break down the latest developments in the 340B program in statehouses and Washington, D.C. The team covers the intensifying fight over state-level 340B legislation and the reemergence of a controversial dark-money ad ca…
  continue reading
 
In this new episode, Ted Slafsky catches up with Will Newton and Bella Czajkowski to analyze the latest 340B developments at both the federal and state levels, plus new scrutiny over the program and some of its stakeholders. With the 119th Congress underway, Ted explains what House and Senate committees and lawmakers 340B stakeholders should keep a…
  continue reading
 
In this final episode of the year, Ted Slafsky, Will Newton and Shannon Young unpack the most significant developments in the 340B program in both recent weeks and 2024. From the escalating legal battles over proposed 340B rebate models and pivotal state legislation to key court decisions and congressional activity, the team provides in-depth analy…
  continue reading
 
Join Ted Slafsky, Shannon Young, Will Newton and Bella Czajkowski for another episode of Inside 340B Report. This week, the team unpacks the latest developments shaping the 340B landscape, from the announcement by drug manufacturers of new rebate models they hope to implement to expanding contract pharmacy restrictions. They also discuss how the in…
  continue reading
 
Ted Slafsky joins Shannon Young, Will Newton and Bella Czajkowski to analyze the 2024 election’s potential impact on the 340B landscape, including how President-elect Donald Trump’s return to the White House and the new GOP-controlled Congress could approach the drug pricing program.The team also discusses Johnson & Johnson’s (J&J) recent lawsuit a…
  continue reading
 
Will Newton hosted this week’s episode, leading a discussion with Shannon Young and Bella Czajkowski. Ted Slafsky was away for this edition, but we look forward to welcoming him back next time. In this new episode, the editorial team explores emerging trends in drugmaker contract pharmacy restrictions, legal developments around 340B eligibility cal…
  continue reading
 
Episode 3: The 340B Rebate Saga: Fallout and Potential Litigation Shannon Young, Will Newton and Bella Czajkowski, explore the biggest developments in the 340B program, focusing on the latest surrounding Johnson & Johnson’s (J&J) rebate proposal, including the potential for litigation. They also recap key discussions from a recent healthcare summit…
  continue reading
 
In episode 2, host Ted Slafsky, along with Will Newton and Bella Czajkowski, recap major news impacting the 340B program, including the future of manufacturer efforts to convert 340B to a rebate, Sen. Bill Cassidy’s latest inquiry into two drugmakers, pushback from bipartisan House members to the rebate proposal federal 340B legislation and key sta…
  continue reading
 
Episode 1: Introducing the Inside 340B Report Editorial Team Welcome to the very first episode of the Inside 340B Report podcast! In this debut episode, host Ted Slafsky, publisher and CEO of 340B Report, introduces listeners to the dynamic editorial team behind the show, Shannon Young, Will Newton, and Bella Czajkowski, as they share their backgro…
  continue reading
 
Inside 340B Report is your exclusive, behind-the-scenes window into the latest news and developments in the 340B drug pricing program, straight from the journalists at 340B Report. Each episode, published twice a month, brings listeners inside 340B Report’s newsroom for a candid, insider’s perspective on the evolving drug pricing policy landscape f…
  continue reading
 
What is caught under the vertical restraints block exemption? Which changes can be expected in comparison to the existing rules? Are you a supplier and retailer: be aware – the rules will change for you! Also, e-tailers and other companies active in the field of online sales will learn during the podcast what is expected to change for them.…
  continue reading
 
In our second DiGi POD episode Roxana Kruse, Peter Giese and Moritz Pottek will present the key aspects of the proposed EU Foreign Subsidy Regulation and explain why this topic is relevant for mergers and acquisitions, public procurement and state aid alike. Find out what could constitute a foreign subsidy, which tools are foreseen to tackle market…
  continue reading
 
In the competition law world, you can hardly avoid the terms online platforms and digital markets these days. But why are there so many discussions around digital markets and why are there concerns around online platforms? In our first DiGi POD episode, Roxana Kruse and Peter Giese will walk you through the most important competition law concepts c…
  continue reading
 
Loading …
Copyright 2025 | Privacy Policy | Terms of Service | | Copyright
Listen to this show while you explore
Play